↓ Skip to main content

Dove Medical Press

Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty…

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
12 Mendeley
Title
Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2020
DOI 10.2147/dmso.s269916
Pubmed ID
Authors

Satoko Kawarasaki, Honami Sawazaki, Hiroaki Iijima, Su-Ping Ng, Jungin Kwon, Shinsuke Mohri, Mari Iwase, Huei-Fen Jheng, Haruya Takahashi, Wataru Nomura, Kazuo Inoue, Teruo Kawada, Tsuyoshi Goto

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 17%
Researcher 2 17%
Student > Bachelor 1 8%
Lecturer 1 8%
Professor > Associate Professor 1 8%
Other 0 0%
Unknown 5 42%
Readers by discipline Count As %
Medicine and Dentistry 2 17%
Biochemistry, Genetics and Molecular Biology 2 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Neuroscience 1 8%
Chemistry 1 8%
Other 0 0%
Unknown 5 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2020.
All research outputs
#22,835,295
of 25,462,162 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1,003
of 1,184 outputs
Outputs of similar age
#380,998
of 441,613 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#37
of 46 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,613 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.